Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (371-380 of 542) with videos related to

Pageof 55
Sort By:
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1990
Cardiovascular surgery prophylaxis. A randomized, controlled comparison of cefazolin and cefuroximeB N Doebbeling, M A Pfaller, K R Kuhns, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.
Archives of Internal Medicine|July 11, 1994
Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriageB N Doebbeling, D R Reagan, M A Pfaller, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1994
Antifungal drug susceptibility testingJ Van Cutsem, H Kurata, H Matsuoka, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)M A Pfaller, R K Flamm, L R Duncan, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1993
Value of the Hybritech ICON Candida Assay in the diagnosis of invasive candidiasis in high-risk patientsM A Pfaller, I Cabezudo, B Buschelman, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants GroupM A Pfaller, R N Jones, G V Doern, et al.
Infection Control and Hospital Epidemiology|December 1, 1996
A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical centerP A Meier, C D Carter, S E Wallace, et al.
Diagnostic Microbiology and Infectious Disease|March 17, 2004
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programM A Pfaller, S A Messer, L Boyken, et al.
Pageof 55

Showing results (371-380 of 542) with videos related to

Sort By:
Pageof 55
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1990
Cardiovascular surgery prophylaxis. A randomized, controlled comparison of cefazolin and cefuroximeB N Doebbeling, M A Pfaller, K R Kuhns, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.
Archives of Internal Medicine|July 11, 1994
Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriageB N Doebbeling, D R Reagan, M A Pfaller, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1994
Antifungal drug susceptibility testingJ Van Cutsem, H Kurata, H Matsuoka, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)M A Pfaller, R K Flamm, L R Duncan, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1993
Value of the Hybritech ICON Candida Assay in the diagnosis of invasive candidiasis in high-risk patientsM A Pfaller, I Cabezudo, B Buschelman, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants GroupM A Pfaller, R N Jones, G V Doern, et al.
Infection Control and Hospital Epidemiology|December 1, 1996
A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical centerP A Meier, C D Carter, S E Wallace, et al.
Diagnostic Microbiology and Infectious Disease|March 17, 2004
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programM A Pfaller, S A Messer, L Boyken, et al.
Pageof 55